Telbivudine

This classification denotes a reverse transcriptase inhibitor with the molecular formula C10H14N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2OC4HKD3SF, chemically known as 2,4(1h,3h)-pyrimidinedione, 1-(2-deoxy-b-l-erythro-pentofuranosyl)-5-methyl- but generally known as telbivudine, which bears US NIH Compound Identifier 159269. European Medicines Agency schedules Telbivudine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25231. The term TELBIVUDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 17, No. 4, 2003, List 50). World Health Organization schedules telbivudine in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule telbivudine under HS 29349990 and SITC 51579. As of Q4 2014, TELBIVUDINE remains the US FDA Preferred Term for this commodity. Telbivudine bears US NLM identifiers UMLS ID C1453933 and NCI Concept Code C66584. SMILES: CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O.